Melanoma antigen recognized by T-cells 1 Uses, Dosage, Side Effects and more

Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).

Attribute	Details
Trade Name	Melanoma antigen recognized by T-cells 1
Generic	Melanoma antigen recognized by T-cells 1
Melanoma antigen recognized by T-cells 1 Other Names	ANTIGEN LB39-AA, ANTIGEN SK29-AA, MART1
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph